Pre-treatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
Mikio Kamimura,1 Akira Taguchi,2 Yukio Nakamura,3,4 Hidefumi Koiwai,5 Shota Ikegami,3 Shigeharu Uchiyama,3 Hiroyuki Kato3 1Center for Osteoporosis and Spinal Disorders, Kamimura Orthopedic Clinic, Matsumoto, Japan; 2Department of Oral and Maxillofacial Radiology, Matsumoto Dental University, Shiojir...
Saved in:
Main Authors: | Kamimura M (Author), Taguchi A (Author), Nakamura Y (Author), Koiwai H (Author), Ikegami S (Author), Uchiyama S (Author), Kato H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment
by: Nakamura Y, et al.
Published: (2018) -
Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa
by: Nakamura Y, et al.
Published: (2018) -
Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018) -
Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment
by: Nakamura Y, et al.
Published: (2017) -
Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018)